Pharmacology of palliative medicine

Seminars in Oncology Nursing

Volumn 21, Issue 1, 2005, Pages 29-35

  Mihelic, Ronald A ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; CORTICOSTEROID; DEXTROMETHORPHAN; FENTANYL; FLUOXETINE; HALOPERIDOL; HYDROMORPHONE; IMIPRAMINE; LAXATIVE; METHADONE; METHOTREXATE; MIDAZOLAM; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; PETHIDINE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

BRADYCARDIA; CANCER PAIN; CHRONIC PAIN; DIGESTIVE SYSTEM CANCER; DNA POLYMORPHISM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; GASTROINTESTINAL ABSORPTION; HUMAN; ILEUS; INTESTINE SURGERY; KIDNEY CARCINOMA; LIVER METABOLISM; MALABSORPTION; MULTIPLE MYELOMA; NEPHROTOXICITY; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEROTONIN SYNDROME; SIDE EFFECT; SMALL INTESTINE;

EID: 13544251461     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.soncn.2004.10.005     Document Type: Article

References (34)

1. T.A. Melvin The primary care physician and palliative care Prim Care 28 2001 239 249
2. D. Doyle, G.W. Hanks, N. Cherney Introduction D. Doyle G.W. Hanks Oxford Textbook of Palliative Medicine 2003 Oxford University Press New York, NY 3 8
3. S.A. Bernard, E. Bruera Drug interactions in palliative care J Clin Oncol 18 2000 1780 1799
4. L. Shargel, A. Yu Applied Biopharmaceutics & Pharmacokinetics 1999 Appleton & Lange Stamford, CT
5. V. Kirishnan, M. Patrick Pharmacological issues in the critically ill Clin Chest Med 24 2003 671 688
6. P.M. Podrazik, J.B. Schwartz Cardiovascular pharmacology of aging Cardiol Clin 17 1999 17 34
7. R.J. Beyth, R.I. Shorr Principles of drug therapy in older patients Rational drug prescribing Clin Geriatr Med 18 2002 577 592
8. A. Vigano, E. Bruera, M.E. Suarez-Almazor Age, pain intensity, and opioid dose in patients with advanced cancer Cancer 83 1998 1244 1250
9. A. Bodenham, M.P. Shelly, G.R. Park The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients Clin Pharmacokinet 14 1998 347 373
10. P.O. Gubbins, K.E. Bertch Drug absorption in gastrointestinal disease and surgery Clin Pharmacokinet 219 1991 431 447
11. K.N. Jeejeebhoy Short bowel syndrome A nutritional and medical approach CMAJ 166 2002 1297 1302
12. B.J. Cusak, R.E. Vestal Clinical pharmacology special considerations in the elderly E. Calkins P.J. Davis A.B. Ford The Practice of Geriatrics 1986 Saunders Philadelphia, PA 115 134
13. D.S. Chutka, J.M. Evans, K.C. Fleming Drug prescribing in the elderly Mayo Clin Proc 70 1995 685 693
14. S.F. Chang, L. Moore, Y.W. Chien Pharmacokinetics and bioavailability of hydromorphone Effects of various routes of administration Pharm Res 5 1988 718 721
15. S. Grond, L. Radbruch, K.A. Lehmann Clinical pharmacokinetics of transdermal opioids Clin Pharmacokinet 38 2000 59 89
16. S.A. Bernard The interaction of medications used in palliative care Hematol Oncol Clin North Am 16 2002 641 655
17. L. Ereshefsky, C. Rieseman, Y.W. Lam Antidepressant drug interactions and the cytochrome P450system Clin Pharmacokinet 29 suppl 1 1995 10 18 discussion 18-19
18. K.K. Kuebler, J. Varga, R.A. Mihelic Why there is no cookbook approach to palliative care Implications of the P450 enzyme system Clin J Oncol Nurs 7 2003 569 572
19. J.F. Rogers, A.N. Nafziger, J.S. Bertino Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs Am J Med 113 2002 746 750
20. M. Corcoran Polypharmacy in the older patient with cancer Cancer Control 4 1997 419 428
21. R. Fainsinger, E. Bruera, S. Watanabe Commonly prescribed medications in advanced cancer patients Presented at the 6th Canadian Palliative Care Conference 1995 Nova Scotia Halifax
22. L. Ereshesfky Drug-drug interactions involving antidepressants Focus on venlafaxine J Clin Psychopharmacol 16 1996 37S 49S
23. C. Risenman Antidepressant drug interactions and the cytochrome P450 system A critical appraisal Pharmacotherapy 15 1995 84S 99S
24. D.C. Goff, K.K. Midha, A.W. Brotman Elevation of plasma concentrations of haloperidol after the addition of fluoxetine Am J Psychiatry 148 1991 790 792
25. M.H. Stein Tardive dyskinesia in a patient taking haloperidol and fluoxetine Am J Psychiatry 148 1991 683 (abstr)
26. J.L. Tate Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine Am J Psychiatry 146 1989 399 400
27. T.G. Tong, S.M. Pond, M.J. Kreek Phenytoin-induced methadone withdrawal Ann Intern Med 94 1981 349 351
28. D.F. Davies, N.W. Shock Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males J Clin Invest 29 1950 496 507
29. J.W. Rowe, R. Andres, J.D. Tobin The effect of age on creatinine clearance in men A cross-sectional and longitudinal study J Gerontol 31 1976 155 163
30. G. D'Honneur, A. Gilton, P. Sandouk Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine The influence of renal failure Anesthesiology 81 1994 87 93
31. K.A. Lehmann, D. Zech Morphine-6-glucuronide, a pharmacologically active morphine metabolite A review of the literature Eur J Pain 12 1993 28 35
32. F.M. Gloth Concerns with chronic analgesic therapy in elderly patients Am J Med 101 suppl 1A 1996 19S 24S
33. K. Turnheim When drug therapy gets old pharmacokinetics and pharmacodynamics in the elderly Exp Gerontol 38 2003 843 853
34. R. Loebstein, H. Yonath, D. Peleg Interindividual variability in sensitivity to warfarin--Nature or nurture? Clin Pharmacol Ther 70 2001 159 164